Global UV Infection Control Devices Market - 2022-2029

Global UV Infection Control Devices Market - 2022-2029

Market Overview

UV Infection Control Devices Market size was valued US$ 2546 million in 2021 and is estimated to reach US$ 8793 million by 2029, growing at a CAGR of 12.4% during the forecast period (2022-2029).

The UV infection control devices are the equipment used to kill microorganisms, including bacteria, viruses, protozoa, fungi, and other microbes, using ultraviolet (UV) light. These devices are used to sterilize, sanitize, and disinfect the medical products used in healthcare settings. These devices kill the microbes by emitting the UV light that penetrates the microorganism cells and leads to oxidative damage and cell death.

Market Dynamics

The rising R&D initiatives, rising demand for UV infection control devices with the rising incidence of hospital acquired infections are the factors that are driving the market's growth over the forecast period.

Increasing novel technological advancements and rising incidence of hospital acquired infections are expected to drive market growth.

The market is driven by the rising demands for UV infection control devices with the rising prevalence of hospital-acquired infections (HAI) along with the increase in the number of patients admitted in the healthcare setting, including the hospital, long-term care facility, emergency department, outpatient clinic, physicians' offices, community health center, and others. Hospital-acquired infections (HAI) are the most frequent adverse event in health-care delivery worldwide. According to the World Health Organization (WHO), out of every 100 hospitalized patients at any given time, 7 in developed and 10 in developing countries would be suffering from at least one hospital-acquired infection. Approximately 30% of patients in intensive care units (ICU) are affected by at least one hospital-acquired infection in high-income countries. In contrast, the frequency of developing hospital-acquired infections is at least 2─3 fold higher in the low- and middle-income countries compared to the high-income countries.

The rise in the approval or launch of novel products shall stimulate market growth. For instance, in February 2020, Biocoat, Inc. had launched the UV-Curable Hydrophilic Coating, i.e., HYDAK UV. The HYDAK coating is designed to be cured using ultraviolet (UV) light. It allows flexible integration with industry-standard UV coating systems. It is built by using Biocoat's existing thermal heat cure coating technology.

In March 2020, the Spectral and Advanced Ultra-Violet Systems had received the theAUVS UV Box's approval for use with Spectralink Versity mobile phones. The AUVS UV Box provides a unique infection control system to protect patients and staff from pathogens, reduce hospital-acquired Infections (HAI) and support healthcare infection prevention protocols when used in conjunction with the Spectralink Versity enterprise smartphone.

There are rising technology adoption, advanced ultraviolet infection control devices and advanced data collection and reporting capabilities. For instance, Optimum-UV Enlight, developed by Ultraviolet Devices, Inc. & Clorox Healthcare, combines powerful UV technology and advanced data collection and reporting capabilities. It provides an effective UV solution for killing the hospital-associated infection HAI-causing pathogens like Clostridium difficile, methicillin-resistant staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and carbapenem-resistant Enterobacteriaceae (CRE). It comprises cloud reporting and analytics, an enhanced user interface, bulbs designed for optimum UV-C energy emission, and more. It delivers the programmed dose of short-wavelength ultraviolet light (UV-C) to kill pathogens present on the hospital surfaces. It effectively kills the 31 pathogens in five minutes at a distance of eight feet and provides accurate reports of infection rates and outbreaks to enhance patient safety efforts. However, the market is hindered by the high cost of the UV Infection Control Devices and the government regulations, which vary as per the country.

High cost associated with UV infection control devices is expected to hamper the market growth.

The global UV infection control device market is hindered by the high cost of the UV Infection Control Devices and the government regulations, which vary as per the country.

Industry Analysis

The global UV infection control devices market provides in-depth analysis of the market based on various industry factors such as Porter’s Five Forces, Regulatory and Reimbursement Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis/B>

Product type segment is expected to hold the largest market share in global UV infection control devices market

The UV infection control devices market is segmented on product types like mobile, stationary, and others. The mobile segment accounts for the highest market share. There is a rising demand for mobile UV infection control devices due to their versatility and mobility properties. It has the ability to move to different locations because of its lightweight and ease to use. The market is dominated by the availability of cost-effective mobile UV infection control devices.

The stationary segment is expected to have a positive market share over the forecasted period. The stationary UV infection control devices cannot be moved as these devices are fixed to one location. These devices are expensive in comparison to mobile UV infection control devices.

Further, the market is also classified based on end-users as hospitals, clinics & laboratories, medical device companies, pharmaceutical companies, etc. The hospital segment accounts for the highest market share due to the higher penetration of UV infection control devices and the rising prevalence of hospital-acquired infections (HAI). The drastic growth in the number of hospitals shall boost the demand for UV infection control devices. According to the American Hospital Association, the number of hospitals was 6,093 in 2020 and is expected to increase over the forecasted period. Several organizations, associations, and institutes are involved in creating awareness regarding hospital infection control measures. For instance, the Society for Healthcare Epidemiology of America, the Infectious Disease Society of America had developed recommendations for controlling six of the potentially most dangerous infections that occur in hospitals, including the surgical site infections, ventilator-associated pneumonia, central line-associated bloodstream infections, catheter-associated urinary tract infections, Methicillin-resistant Staphylococcus aureus, and Clostridium Dificille. The Centers for Disease Control and Prevention provide free online training courses to help healthcare organizations prevent and control infections.

Geographical Analysis

North America region holds the largest market share in the global UV infection control devices market

By region, the UV infection control devices market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the UV infection control devices market due to the higher adoption of advanced UV infection control devices. According to the Clorox Healthcare Company’s website, the Optimum-UV Enlight System is successfully used by more than 300 hospitals and four of the top five IDNs across the United States. The high prevalence of hospital-associated infections shall fuel the market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 99,000 deaths are estimated each year that are related to healthcare associated infections. Several organizations and associations are involved in creating awareness regarding UV infection control devices. Moreover, the presence of many hospitals, clinics & laboratories, pharmaceutical companies shall boost the demand for UV infection control devices over the forecasted period.

The Asia-Pacific region is expected to have positive market growth over the forecasted period. The low level of hygiene in hospitals, poor infrastructure management, and poor sterilizing techniques leads to hospital-associated infections, especially in developing countries. The growing associations and organization's initiatives for promoting cost-effective infection control practices shall fuel the market growth. For instance, the Asia Pacific Society of Infection Control (APSIC) provides advanced infection control practice to reduce hospital-associated infections and control emerging and re-emerging infectious diseases and improve the patient's outcome hospitals. It is entering into a collaboration with the non-government and government organizations to facilitate quality improvement initiatives and infection control research throughout the Asia Pacific region.

Competitive Landscape

Several international and local market players are present in the market. Product diversification, revenue generation, new product launch, and opportunities intensify the market competition. Getinge Group, STERIS plc, Xenex, Seal Shield, American Ultraviolet, and AquiSense Technologies are the leading market players with significant market share.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for UV Infection Control Devices and their expansion across the globe. For instance, in February 2020, Clorox Healthcare had entered into the collaboration with Ultraviolet Devices, Inc. (UVDI) to introduce the Clorox Healthcare Optimum-UV System. Both the companies would combine the power of manual surface disinfection with advanced ultraviolet (UV) technology to deliver an even more comprehensive surface disinfection solution. In June 2019, Clorox Healthcare had entered into the collaboration with HP Healthcare for innovation in disinfectant efficacy and surface compatibility and a longstanding commitment to supporting safe and compliant product use.

The companies are raising the funding and investment to increase their market penetration. For instance, in March 2019, Barrett Hospital & HealthCare had invested in two innovative Clorox Healthcare Optimum-UV Enlight Systems. This technology is used to protect the hospital environment by killing pathogens that can cause healthcare-associated infections (HAIs).

Key Companies to Watch

Carl Zeiss AG:

Overview: Getinge is a medical technology company that develops equipment and syatem related to life sciences and healthcare. It was founded in 1904 and is headquartered in Gothenburg, Sweden. Their products include Sterilized Equipment, Disinfectant, ventilators, bioreactors etc.

Product Portfolio:

DPTE Beta Containers: The stainless steel DPTE Beta Containers are reusable and are developed for steam sterilization procedure. The solid mechanical design provides safe transfer of complex and heavy parts.

Key Developments: On April 2022, Getinge announced acquisition of FLUOPTICS SAS, a fluorescence imaging company.

The global UV infection control devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.